1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
17.21%
Revenue growth 1.25-1.5x RUN's 12.90%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
-72.55%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-60.26%
Negative EBIT growth while RUN is at 23.91%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-42.37%
Negative operating income growth while RUN is at 0.47%. Joel Greenblatt would press for urgent turnaround measures.
-95.09%
Negative net income growth while RUN stands at 460.66%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-114.57%
Negative EPS growth while RUN is at 456.14%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-115.69%
Negative diluted EPS growth while RUN is at 436.85%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.25%
Share reduction more than 1.5x RUN's 1.22%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.08%
Diluted share reduction more than 1.5x RUN's 1.26%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
17.58%
Positive OCF growth while RUN is negative. John Neff would see this as a clear operational advantage vs. the competitor.
130.50%
FCF growth 75-90% of RUN's 156.78%. Bill Ackman might push for improved capital allocation or operational changes to match the competitor.
7074.36%
10Y revenue/share CAGR above 1.5x RUN's 231.43%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
7074.36%
5Y revenue/share CAGR above 1.5x RUN's 64.82%. David Dodd would look for consistent product or market expansions fueling outperformance.
409.05%
Positive 3Y CAGR while RUN is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
4274.13%
Positive long-term OCF/share growth while RUN is negative. John Neff would see a structural advantage in sustained cash generation.
4274.13%
Positive OCF/share growth while RUN is negative. John Neff might see a comparative advantage in operational cash viability.
251.21%
Positive 3Y OCF/share CAGR while RUN is negative. John Neff might see a big short-term edge in operational efficiency.
107.09%
Below 50% of RUN's 1473.60%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
107.09%
Below 50% of RUN's 1185.12%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-94.13%
Negative 3Y CAGR while RUN is 220.80%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
95.42%
Positive short-term equity growth while RUN is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-11.89%
Firm’s AR is declining while RUN shows 8.37%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-15.43%
Inventory is declining while RUN stands at 18.52%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.05%
Asset growth at 50-75% of RUN's 4.18%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
1.36%
Under 50% of RUN's 11.80%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
9.12%
Debt growth far above RUN's 3.38%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
3.94%
We increase R&D while RUN cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
35.79%
We expand SG&A while RUN cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.